MiMedx Group, Inc. (MDXG) Operating Margin
- Operating margin · 12 months: Value 2.46%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 2.46% | Operating income / revenue. Period ending 2026-06-30. $8.75M ÷ $355.17M × 100 ≈ 2.46% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 8.75M USD | Operating Income (Loss) |
| Revenue | 355.17M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 75.12M USD | Cost of Goods and Services Sold |
| Research and development | 15.38M USD | Research and Development Expense |
| Selling, general and administration | 255.08M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8.75M | $355.17M | $75.12M | $15.38M | $255.08M | 2.46% |
| 2026-03-31 | $39.59M | $389.42M | $73.82M | $15.91M | $259.46M | 10.17% |
| 2025-12-31 | $63.89M | $418.63M | $73.01M | $15.10M | $266.19M | 15.26% |
| 2025-09-30 | $53.86M | $393.44M | $70.87M | $13.91M | $254.16M | 13.69% |
| 2025-06-30 | $42.84M | $363.77M | $67.47M | $13.12M | $238.68M | 11.78% |
| 2025-03-31 | $53.92M | $352.38M | $63.64M | $12.83M | $229.93M | 15.30% |
| 2024-12-31 | $58.87M | $348.88M | $60.07M | $12.34M | $225.09M | 16.87% |
| 2024-09-30 | $63.30M | $342.80M | $57.01M | $11.20M | $218.40M | 18.47% |
| 2024-06-30 | $63.26M | $340.46M | $56.47M | $11.36M | $217.45M | 18.58% |
| 2024-03-31 | $50.65M | $334.51M | $55.20M | $12.02M | $214.00M | 15.14% |
| 2023-12-31 | $37.12M | $321.48M | $54.63M | $12.66M | $211.12M | 11.55% |
| 2023-09-30 | $11.29M | $309.02M | $55.16M | $23.57M | $206.72M | 3.65% |
| 2023-06-30 | $-6.63M | $295.00M | $52.56M | $26.35M | $207.63M | -2.25% |
| 2023-03-31 | $-19.05M | $280.62M | $50.80M | $23.36M | $211.50M | -6.79% |
| 2022-12-31 | $-24.97M | $267.84M | $48.32M | $22.83M | $208.79M | -9.32% |
| 2022-09-30 | $-22.74M | $260.88M | $44.70M | $22.00M | $211.91M | -8.72% |
| 2022-06-30 | $-16.71M | $256.26M | $42.64M | $20.42M | $204.72M | -6.52% |
| 2022-03-31 | $-7.48M | $257.54M | $43.58M | $18.97M | $202.53M | -2.91% |
| 2021-12-31 | $-5.04M | $258.62M | $43.28M | $17.34M | $198.36M | -1.95% |
| 2021-09-30 | $-24.43M | $259.75M | $43.35M | $16.20M | $194.00M | -9.40% |
| 2021-06-30 | $-33.06M | $260.98M | $43.51M | $15.21M | $195.75M | -12.67% |
| 2021-03-31 | $-38.51M | $246.47M | $38.95M | $13.40M | $179.48M | -15.62% |
| 2020-12-31 | $-45.40M | $248.23M | $39.33M | $11.71M | $181.02M | -18.29% |
| 2020-09-30 | $-34.18M | $256.09M | $41.22M | $11.00M | $177.76M | -13.35% |
| 2020-06-30 | $-10.27M | $280.65M | $44.14M | $10.32M | $180.97M | -3.66% |
| 2020-03-31 | $-21.49M | $294.44M | $45.69M | $10.89M | $194.28M | -7.30% |
| 2019-12-31 | $-21.16M | $299.25M | $43.08M | $11.14M | $198.21M | -7.07% |
| 2019-09-30 | $-25.23M | $315.44M | $40.77M | $12.96M | $219.06M | -8.00% |
| 2019-06-30 | $-39.06M | $313.54M | $34.92M | $14.23M | $226.54M | -12.46% |
| 2019-03-31 | $-20.31M | $341.52M | $34.45M | $15.12M | $243.48M | -5.95% |
| 2018-12-31 | $-3.92M | $359.11M | $36.39M | $15.77M | $258.53M | -1.09% |
| 2018-09-30 | (m) | $354.38M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $351.42M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $336.49M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $46.22M | $321.14M | $35.22M | $17.90M | $220.12M | 14.39% |
| 2017-09-30 | $30.96M | (m) | (m) | $17.89M | $216.90M | (m) |
| 2017-06-30 | $26.82M | (m) | (m) | $15.32M | $204.84M | (m) |
| 2017-03-31 | $23.16M | (m) | (m) | $13.74M | $192.30M | (m) |
| 2016-12-31 | $18.45M | (m) | (m) | $12.04M | $180.00M | (m) |
| 2016-09-30 | $17.48M | (m) | (m) | $10.92M | $168.12M | (m) |
| 2016-06-30 | $19.49M | (m) | (m) | $10.19M | $154.84M | (m) |
| 2016-03-31 | $21.58M | (m) | (m) | $9.08M | $144.72M | (m) |
| 2015-12-31 | $24.36M | (m) | (m) | $8.41M | $133.38M | (m) |
| 2015-09-30 | $21.27M | (m) | (m) | $7.92M | $126.10M | (m) |
| 2015-06-30 | $18.28M | (m) | (m) | $7.75M | $115.39M | (m) |
| 2015-03-31 | $12.24M | (m) | (m) | $7.49M | $103.94M | (m) |
| 2014-12-31 | $7.10M | (m) | (m) | $7.05M | $90.48M | (m) |
| 2014-09-30 | $1.04M | (m) | (m) | $6.59M | $75.51M | (m) |
| 2014-06-30 | $-2.95M | (m) | (m) | $5.86M | $64.03M | (m) |
| 2014-03-31 | $-3.30M | (m) | (m) | $4.99M | $53.71M | (m) |
| 2013-12-31 | $-2.64M | (m) | (m) | $4.84M | $46.23M | (m) |
| 2013-09-30 | $-2.20M | (m) | (m) | $4.59M | $41.48M | (m) |
| 2013-06-30 | $-5.58M | (m) | (m) | $4.15M | $34.52M | (m) |
| 2013-03-31 | $-4.95M | (m) | (m) | $3.72M | $26.70M | (m) |
| 2012-12-31 | $-5.36M | (m) | (m) | $2.88M | $20.97M | (m) |
| 2012-09-30 | $-6.82M | (m) | (m) | $2.04M | $16.63M | (m) |
| 2012-06-30 | $-4.84M | (m) | (m) | $1.76M | $12.78M | (m) |
| 2012-03-31 | $-7.14M | (m) | (m) | $2.05M | $12.11M | (m) |
| 2011-12-31 | $-9.76M | $7.76M | (m) | $2.60M | $11.76M | -125.78% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-10.53M | $788.87K | (m) | $2.75M | $6.85M | -1335.15% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |